In a recent study, researchers examined how the dose of daily aspirin affects the risk of adverse cardiovascular disease events in patients with established cardiovascular disease.
The authors of a recent study examined how the use of aspirin in combination with direct oral anticoagulants in certain cardiovascular patient populations impacted the risk of adverse events.
A prior randomized trial suggested that low-dose aspirin therapy prior to conception did not have positive effects on pregnancy outcomes. Researchers conducted a per protocol, post-hoc analysis of the trial...
In a recent study, researchers employed umbrella review methodology to better quantify the risk-benefit balance of low-dose aspirin use in patients with and without cardiovascular disease.
In a new post-hoc analysis, researchers investigated the risks and benefits of aspirin use among patients with atrial fibrillation with recent acute coronary syndrome or percutaneous coronary intervention....
Because the role of low‐dose aspirin for the primary prevention of cardiovascular disease among different racial and ethnic groups is unclear, authors of a new study sought to determine the association...
In a recent study, researchers sought to examine trends in the use of aspirin for primary and secondary prevention of cardiovascular disease among adults in the US.
In a recent large clinical trial, researchers investigated the effects of daily aspirin use on outcomes among healthy, community-dwelling older adults, including rates of mortality, dementia, persistent...
After noting that only modest benefits have been seen in long-term CVD prevention with aspirin, researchers examined whether bodyweight leading to misdosing could explain these results.
